Loading data for PSIL — first visit, this takes a few seconds.

AdvisorShares Psychedelic...

NYSEArca: PSIL · Real-Time Price · USD
25.98
-0.09 (-0.35%)
At close: Aug 19, 2026, 4:40 PM

AdvisorShares Psychedelics ETF (PSIL) ETF Price, Holdings & Analysis

-0.35%

No data available

Bid0
Market Capn/a
AUM48.53M
NAV25.63
Beta0.56
EPS (ttm)n/a
PE Ratio (ttm)n/a
Shares Outn/a
Inception DateSep 15, 2021
Ask26.89
Volume12,371
Avg. Volume (20D)41,133
Open25.67
Previous Close26.07
Day's Range25.74 - 26.39
52-Week Range15.36 - 26.39
Holdingsn/a
Expense Ratio1.00%

About PSIL

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Asset Class Equity
Ticker Symbol PSIL
Inception Date Sep 15, 2021
Provider Advisorshares
Exchange NYSEArca

Top Sectors

SectorWeight %
Healthcare100.00%
View All Sectors

Top 10 Holdings 70.03% of assets

NameSymbolWeight
Ataibeckley IncATAI14.15%
Definium Therapeutic...DFTX12.05%
Compass Pathways PLC...CMPS9.83%
Helus Pharma Inc Ord...HELP.NE5.47%
Relmada Therapeutics...RLMD5.32%
Gh Research PLCGHRS4.82%
Nrx Pharmaceuticals ...NRXP4.74%
Neurocrine Bioscienc...NBIX4.66%
Alto Neuroscience In...ANRO4.55%
Bright Minds Bioscie...DRUG.CN4.44%
View More Holdings

Dividends Dividend Yield 7.23%

Ex-DividendAmountPayment Date
Dec 22, 2025$1.6840n/a
Sep 22, 2025$0.0200n/a
Jun 23, 2025$0.0120n/a
Mar 21, 2025$0.1630n/a
Dec 23, 2024$0.0550n/a
Full Dividend History